Is Antimicrobial Dosing Adjustment Associated with Better Outcomes in Patients with Severe Obesity and Bloodstream Infections? An Exploratory Study
The impact of adjusted treatment on clinical outcomes in patients with severe obesity is unclear. This study included adults with severe obesity admitted for bloodstream infections between 2005 and 2015. The patients were grouped according to the percentage of the appropriateness of the dosage of th...
Saved in:
Published in | Antibiotics (Basel) Vol. 9; no. 10; p. 707 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
Basel
MDPI AG
01.10.2020
MDPI |
Subjects | |
Online Access | Get full text |
ISSN | 2079-6382 2079-6382 |
DOI | 10.3390/antibiotics9100707 |
Cover
Abstract | The impact of adjusted treatment on clinical outcomes in patients with severe obesity is unclear. This study included adults with severe obesity admitted for bloodstream infections between 2005 and 2015. The patients were grouped according to the percentage of the appropriateness of the dosage of their antimicrobial treatment: 80–100% = good, 20–79% = moderate, and 0–19% = poor. The association between antimicrobial adjustment and a composite of unfavourable outcomes [intensive care unit stay ≥72 h, duration of sepsis >3 days, length of stay ≥7 days or all-cause 30-day mortality] was assessed using logistic regression. Of 110 included episodes, the adjustment was rated good in 47 (43%) episodes, moderate in 31 (28%), and poor in 32 (29%). Older age, Pitt bacteremia score ≥2, sepsis on day 1, and infection site were independent risk factors for unfavourable outcomes. The level of appropriateness was not associated with unfavourable outcomes. The number of antimicrobials, consultation with an infectious disease specialist, blood urea nitrogen 7–10.9 mmol/L, and hemodialysis were significantly associated with adjusted antimicrobial dosing. While the severity of the infection had a substantial impact on the measured outcomes, we did not find an association between dosing optimization and better outcomes. |
---|---|
AbstractList | The impact of adjusted treatment on clinical outcomes in patients with severe obesity is unclear. This study included adults with severe obesity admitted for bloodstream infections between 2005 and 2015. The patients were grouped according to the percentage of the appropriateness of the dosage of their antimicrobial treatment: 80–100% = good, 20–79% = moderate, and 0–19% = poor. The association between antimicrobial adjustment and a composite of unfavourable outcomes [intensive care unit stay ≥72 h, duration of sepsis >3 days, length of stay ≥7 days or all-cause 30-day mortality] was assessed using logistic regression. Of 110 included episodes, the adjustment was rated good in 47 (43%) episodes, moderate in 31 (28%), and poor in 32 (29%). Older age, Pitt bacteremia score ≥2, sepsis on day 1, and infection site were independent risk factors for unfavourable outcomes. The level of appropriateness was not associated with unfavourable outcomes. The number of antimicrobials, consultation with an infectious disease specialist, blood urea nitrogen 7–10.9 mmol/L, and hemodialysis were significantly associated with adjusted antimicrobial dosing. While the severity of the infection had a substantial impact on the measured outcomes, we did not find an association between dosing optimization and better outcomes. The impact of adjusted treatment on clinical outcomes in patients with severe obesity is unclear. This study included adults with severe obesity admitted for bloodstream infections between 2005 and 2015. The patients were grouped according to the percentage of the appropriateness of the dosage of their antimicrobial treatment: 80-100% = good, 20-79% = moderate, and 0-19% = poor. The association between antimicrobial adjustment and a composite of unfavourable outcomes [intensive care unit stay ≥72 h, duration of sepsis >3 days, length of stay ≥7 days or all-cause 30-day mortality] was assessed using logistic regression. Of 110 included episodes, the adjustment was rated good in 47 (43%) episodes, moderate in 31 (28%), and poor in 32 (29%). Older age, Pitt bacteremia score ≥2, sepsis on day 1, and infection site were independent risk factors for unfavourable outcomes. The level of appropriateness was not associated with unfavourable outcomes. The number of antimicrobials, consultation with an infectious disease specialist, blood urea nitrogen 7-10.9 mmol/L, and hemodialysis were significantly associated with adjusted antimicrobial dosing. While the severity of the infection had a substantial impact on the measured outcomes, we did not find an association between dosing optimization and better outcomes.The impact of adjusted treatment on clinical outcomes in patients with severe obesity is unclear. This study included adults with severe obesity admitted for bloodstream infections between 2005 and 2015. The patients were grouped according to the percentage of the appropriateness of the dosage of their antimicrobial treatment: 80-100% = good, 20-79% = moderate, and 0-19% = poor. The association between antimicrobial adjustment and a composite of unfavourable outcomes [intensive care unit stay ≥72 h, duration of sepsis >3 days, length of stay ≥7 days or all-cause 30-day mortality] was assessed using logistic regression. Of 110 included episodes, the adjustment was rated good in 47 (43%) episodes, moderate in 31 (28%), and poor in 32 (29%). Older age, Pitt bacteremia score ≥2, sepsis on day 1, and infection site were independent risk factors for unfavourable outcomes. The level of appropriateness was not associated with unfavourable outcomes. The number of antimicrobials, consultation with an infectious disease specialist, blood urea nitrogen 7-10.9 mmol/L, and hemodialysis were significantly associated with adjusted antimicrobial dosing. While the severity of the infection had a substantial impact on the measured outcomes, we did not find an association between dosing optimization and better outcomes. The impact of adjusted treatment on clinical outcomes in patients with severe obesity is unclear. This study included adults with severe obesity admitted for bloodstream infections between 2005 and 2015. The patients were grouped according to the percentage of the appropriateness of the dosage of their antimicrobial treatment: 80-100% = good, 20-79% = moderate, and 0-19% = poor. The association between antimicrobial adjustment and a composite of unfavourable outcomes [intensive care unit stay [greater than or equal to]72 h, duration of sepsis >3 days, length of stay [greater than or equal to]7 days or all-cause 30-day mortality] was assessed using logistic regression. Of 110 included episodes, the adjustment was rated good in 47 (43%) episodes, moderate in 31 (28%), and poor in 32 (29%). Older age, Pitt bacteremia score [greater than or equal to]2, sepsis on day 1, and infection site were independent risk factors for unfavourable outcomes. The level of appropriateness was not associated with unfavourable outcomes. The number of antimicrobials, consultation with an infectious disease specialist, blood urea nitrogen 7-10.9 mmol/L, and hemodialysis were significantly associated with adjusted antimicrobial dosing. While the severity of the infection had a substantial impact on the measured outcomes, we did not find an association between dosing optimization and better outcomes. |
Audience | Academic |
Author | Valiquette, Louis Sirard, Stéphanie Langlois, Marie-France Perron, Julie Abou Chakra, Claire Nour Carignan, Alex |
AuthorAffiliation | 2 Department of Medicine, Division of Endocrinology, Université de Sherbrooke, Sherbrooke, QC J1H 5N4, Canada; marie-france.langlois@usherbrooke.ca 3 Department of Pharmacy, Centre Intégré Universitaire de Santé et de Services Sociaux de l’Estrie-Centre Hospitalier Universitaire de Sherbrooke, Granby, QC J2G 1T7, Canada; julie.perron2@usherbrooke.ca 1 Department of Microbiology and Infectious Diseases, Université de Sherbrooke, Sherbrooke, QC J1H 5N4, Canada; stephanie.sirard@USherbrooke.ca (S.S.); claire.nour.abou.chakra@usherbrooke.ca (C.N.A.C.); alex.carignan@usherbrooke.ca (A.C.) |
AuthorAffiliation_xml | – name: 3 Department of Pharmacy, Centre Intégré Universitaire de Santé et de Services Sociaux de l’Estrie-Centre Hospitalier Universitaire de Sherbrooke, Granby, QC J2G 1T7, Canada; julie.perron2@usherbrooke.ca – name: 1 Department of Microbiology and Infectious Diseases, Université de Sherbrooke, Sherbrooke, QC J1H 5N4, Canada; stephanie.sirard@USherbrooke.ca (S.S.); claire.nour.abou.chakra@usherbrooke.ca (C.N.A.C.); alex.carignan@usherbrooke.ca (A.C.) – name: 2 Department of Medicine, Division of Endocrinology, Université de Sherbrooke, Sherbrooke, QC J1H 5N4, Canada; marie-france.langlois@usherbrooke.ca |
Author_xml | – sequence: 1 givenname: Stéphanie surname: Sirard fullname: Sirard, Stéphanie – sequence: 2 givenname: Claire Nour surname: Abou Chakra fullname: Abou Chakra, Claire Nour – sequence: 3 givenname: Marie-France surname: Langlois fullname: Langlois, Marie-France – sequence: 4 givenname: Julie orcidid: 0000-0001-7454-7840 surname: Perron fullname: Perron, Julie – sequence: 5 givenname: Alex surname: Carignan fullname: Carignan, Alex – sequence: 6 givenname: Louis orcidid: 0000-0002-8300-8416 surname: Valiquette fullname: Valiquette, Louis |
BookMark | eNp9kktvFDEMx0eoiD7oF-AUiQuXhbzmdQFtS4GVKi1S4Rx5Es82q5lkSTIt-zn4ws12K6BFIpdYzs9_O7aPiwPnHRbFK0bfCtHSd-CS7axPVseWUVrT-llxxGndzirR8IO_7MPiNMY1zadloqHNi-JQCNow1vKj4tciknmWGq0OvrMwkI8-Wrcic7OeYhrRJTKP0WsLCQ25temanGFKGMhyStqPGIl15Cskm9G4B67wBgOSZYfRpi0BZ8jZ4L2JKSCMZOF61Ml6Fz_k3OTi52bwAZIPW3KVJrN9WTzvYYh4-nCfFN8_XXw7_zK7XH5enM8vZ7qkLM2gNlpTTeuS96Voq5JBa1jHtEZWyb7usl1KZjSXsioBTCNFzaq-o5r3ICpxUiz2usbDWm2CHSFslQer7h0-rBSE3OABFZMd6ymTtWyYBNF3psMOGi0RJFIDWev9XmszdSManZsRYHgk-vjF2Wu18jeqrihv7ot58yAQ_I8JY1KjjRqHARz6KSouS97WDaVlRl8_Qdd-Ci63SvFSli1rKZd_qBXkD1jX-5xX70TVvJJcNKxiO4rvqTz-GAP2v0tmVO0WTf27aDmoeRKkbYLdRHMKO_wv9A4Oc9-I |
CitedBy_id | crossref_primary_10_1186_s12879_021_06682_8 |
Cites_doi | 10.1016/j.amjmed.2008.01.046 10.2165/11318100-000000000-00000 10.1007/s11908-015-0493-6 10.1016/j.jinf.2017.09.009 10.1093/jac/dkv189 10.1007/s00134-017-4683-6 10.1016/j.ijantimicag.2012.09.004 10.1093/ije/dyx091 10.1016/j.ijantimicag.2016.01.009 10.1128/AAC.00531-19 10.1002/jcph.505 10.1002/phar.1327 10.1007/s11695-008-9477-z 10.1038/ijo.2012.62 10.1002/pds.3461 10.1007/s10096-016-2835-1 10.1097/SHK.0b013e318182f98f 10.1002/phar.2023 10.1002/j.1875-9114.2012.01098.x 10.1001/dmp.2010.40 10.1016/j.jemermed.2012.11.051 10.1093/cid/ciu296 10.1111/1469-0691.12195 10.7326/0003-4819-140-1-200401060-00008 10.1016/j.ajem.2018.09.011 10.2147/DDDT.S181834 10.1016/j.jiac.2016.07.006 10.1097/IPC.0000000000000711 10.1016/S1473-3099(06)70523-0 10.1097/MJT.0000000000000401 10.1056/NEJMoa1614362 10.1016/j.ajem.2011.05.027 10.1177/2150131915583659 10.1016/j.jinf.2012.03.013 |
ContentType | Journal Article |
Copyright | COPYRIGHT 2020 MDPI AG 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. 2020 by the authors. 2020 |
Copyright_xml | – notice: COPYRIGHT 2020 MDPI AG – notice: 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: 2020 by the authors. 2020 |
DBID | AAYXX CITATION 7QL 7T7 8FD 8FE 8FH ABUWG AFKRA AZQEC BBNVY BENPR BHPHI C1K CCPQU DWQXO FR3 GNUQQ HCIFZ LK8 M7P P64 PHGZM PHGZT PIMPY PKEHL PQEST PQGLB PQQKQ PQUKI PRINS 7X8 5PM DOA |
DOI | 10.3390/antibiotics9100707 |
DatabaseName | CrossRef Bacteriology Abstracts (Microbiology B) Industrial and Applied Microbiology Abstracts (Microbiology A) Technology Research Database ProQuest SciTech Collection ProQuest Natural Science Journals ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials Biological Science Collection ProQuest Central Natural Science Collection Environmental Sciences and Pollution Management ProQuest One ProQuest Central Engineering Research Database ProQuest Central Student SciTech Premium Collection Biological Sciences Biological Science Database Biotechnology and BioEngineering Abstracts ProQuest Central Premium ProQuest One Academic (New) Publicly Available Content Database ProQuest One Academic Middle East (New) ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
DatabaseTitle | CrossRef Publicly Available Content Database ProQuest Central Student Technology Research Database ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest Natural Science Collection ProQuest Central China Environmental Sciences and Pollution Management ProQuest Central ProQuest One Applied & Life Sciences Natural Science Collection ProQuest Central Korea Bacteriology Abstracts (Microbiology B) Biological Science Collection Industrial and Applied Microbiology Abstracts (Microbiology A) ProQuest Central (New) ProQuest Biological Science Collection ProQuest One Academic Eastern Edition Biological Science Database ProQuest SciTech Collection Biotechnology and BioEngineering Abstracts ProQuest One Academic UKI Edition Engineering Research Database ProQuest One Academic ProQuest One Academic (New) MEDLINE - Academic |
DatabaseTitleList | Publicly Available Content Database CrossRef MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: BENPR name: ProQuest Central url: http://www.proquest.com/pqcentral?accountid=15518 sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Pharmacy, Therapeutics, & Pharmacology |
EISSN | 2079-6382 |
ExternalDocumentID | oai_doaj_org_article_14b1f01474814a3fbdbeba8c4ea4e0da PMC7602836 A642381614 10_3390_antibiotics9100707 |
GeographicLocations | Canada |
GeographicLocations_xml | – name: Canada |
GroupedDBID | 53G 5VS 8FE 8FH AADQD AAFWJ AAHBH AAYXX ADBBV AFKRA AFPKN AFZYC ALMA_UNASSIGNED_HOLDINGS AOIJS BBNVY BCNDV BENPR BHPHI CCPQU CITATION ECGQY GROUPED_DOAJ HCIFZ HYE IAO IHR KQ8 LK8 M48 M7P MODMG M~E OK1 PGMZT PHGZM PHGZT PIMPY PROAC RPM 7QL 7T7 8FD ABUWG AZQEC C1K DWQXO FR3 GNUQQ P64 PKEHL PQEST PQGLB PQQKQ PQUKI PRINS 7X8 PUEGO 5PM |
ID | FETCH-LOGICAL-c501t-a7dcc0c0752f539651a9d1b1cce164f7b1b1541dc24465aad843716fb0c2fa363 |
IEDL.DBID | M48 |
ISSN | 2079-6382 |
IngestDate | Wed Aug 27 01:32:55 EDT 2025 Thu Aug 21 17:09:39 EDT 2025 Fri Sep 05 12:22:39 EDT 2025 Fri Jul 25 10:44:50 EDT 2025 Tue Jun 17 21:39:19 EDT 2025 Tue Jul 01 02:09:35 EDT 2025 Thu Apr 24 23:07:46 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 10 |
Language | English |
License | https://creativecommons.org/licenses/by/4.0 Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c501t-a7dcc0c0752f539651a9d1b1cce164f7b1b1541dc24465aad843716fb0c2fa363 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
ORCID | 0000-0002-8300-8416 0000-0001-7454-7840 |
OpenAccessLink | http://journals.scholarsportal.info/openUrl.xqy?doi=10.3390/antibiotics9100707 |
PMID | 33081192 |
PQID | 2545919024 |
PQPubID | 2032437 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_14b1f01474814a3fbdbeba8c4ea4e0da pubmedcentral_primary_oai_pubmedcentral_nih_gov_7602836 proquest_miscellaneous_2452978005 proquest_journals_2545919024 gale_infotracmisc_A642381614 crossref_primary_10_3390_antibiotics9100707 crossref_citationtrail_10_3390_antibiotics9100707 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2020-10-01 |
PublicationDateYYYYMMDD | 2020-10-01 |
PublicationDate_xml | – month: 10 year: 2020 text: 2020-10-01 day: 01 |
PublicationDecade | 2020 |
PublicationPlace | Basel |
PublicationPlace_xml | – name: Basel |
PublicationTitle | Antibiotics (Basel) |
PublicationYear | 2020 |
Publisher | MDPI AG MDPI |
Publisher_xml | – name: MDPI AG – name: MDPI |
References | Grissom (ref_22) 2010; 4 Stevens (ref_34) 2014; 59 Rahmatinejad (ref_23) 2019; 37 Rhee (ref_17) 2009; 31 Chung (ref_37) 2015; 55 Liang (ref_32) 2015; 17 Falagas (ref_2) 2006; 6 Nault (ref_24) 2017; 72 Hall (ref_28) 2008; 121 Longo (ref_8) 2013; 22 Alobaid (ref_5) 2016; 47 Charani (ref_27) 2015; 70 Davis (ref_29) 2013; 33 Abdullahi (ref_6) 2008; 18 Goto (ref_11) 2013; 19 Roe (ref_31) 2012; 30 Theofiles (ref_9) 2015; 6 Rhodes (ref_33) 2017; 43 Aretha (ref_26) 2016; 2016 Hanley (ref_4) 2010; 49 Winter (ref_21) 2012; 32 Meng (ref_19) 2017; 37 ref_25 ref_1 Rosini (ref_30) 2013; 44 Cox (ref_35) 2017; 75 Lam (ref_15) 2019; 63 Huttunen (ref_3) 2013; 37 Paterson (ref_18) 2004; 140 Lines (ref_16) 2019; 27 Lizza (ref_14) 2016; 22 Halilovic (ref_7) 2012; 65 Ibrahim (ref_10) 2018; 12 Paulsen (ref_12) 2017; 46 Srinivas (ref_20) 2018; 25 Cheatham (ref_36) 2013; 41 Atamna (ref_13) 2017; 36 |
References_xml | – volume: 121 start-page: 515 year: 2008 ident: ref_28 article-title: Multicenter evaluation of vancomycin dosing: Emphasis on obesity publication-title: Am. J. Med. doi: 10.1016/j.amjmed.2008.01.046 – volume: 49 start-page: 71 year: 2010 ident: ref_4 article-title: Effect of obesity on the pharmacokinetics of drugs in humans publication-title: Clin. Pharmacokinet. doi: 10.2165/11318100-000000000-00000 – volume: 17 start-page: 493 year: 2015 ident: ref_32 article-title: Empiric antimicrobial therapy in severe sepsis and septic shock: Optimizing pathogen clearance publication-title: Curr. Infect. Dis. Rep. doi: 10.1007/s11908-015-0493-6 – volume: 75 start-page: 486 year: 2017 ident: ref_35 article-title: Clinical outcomes in patients hospitalized with cellulitis treated with oral clindamycin and trimethoprim-sulfamethoxazole: The role of weight-based dosing publication-title: J. Infect. doi: 10.1016/j.jinf.2017.09.009 – volume: 70 start-page: 2906 year: 2015 ident: ref_27 article-title: Antimicrobial therapy in obesity: A multicentre cross-sectional study publication-title: J. Antimicrob. Chemother. doi: 10.1093/jac/dkv189 – volume: 43 start-page: 304 year: 2017 ident: ref_33 article-title: Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016 publication-title: Intensive Care Med. doi: 10.1007/s00134-017-4683-6 – volume: 41 start-page: 52 year: 2013 ident: ref_36 article-title: Steady state pharmacokinetics and pharmacodynamics of piperacillin and tazobactam administered by prolonged infusion in obese patients publication-title: Int. J. Antimicrob. Agents doi: 10.1016/j.ijantimicag.2012.09.004 – volume: 46 start-page: 1573 year: 2017 ident: ref_12 article-title: Associations of obesity and lifestyle with the risk and mortality of bloodstream infection in a general population: A 15-year follow-up of 64 027 individuals in the HUNT Study publication-title: Int. J. Epidemiol. doi: 10.1093/ije/dyx091 – volume: 47 start-page: 259 year: 2016 ident: ref_5 article-title: Effect of obesity on the pharmacokinetics of antimicrobials in critically ill patients: A structured review publication-title: Int. J. Antimicrob. Agents doi: 10.1016/j.ijantimicag.2016.01.009 – volume: 63 start-page: e00531-19 year: 2019 ident: ref_15 article-title: Clinical and microbiological outcomes in obese patients receiving colistin for carbapenem-resistant gram-negative bloodstream infection publication-title: Antimicrob. Agents Chemother. doi: 10.1128/AAC.00531-19 – volume: 55 start-page: 899 year: 2015 ident: ref_37 article-title: Population pharmacokinetics and pharmacodynamics of piperacillin and tazobactam administered by prolonged infusion in obese and nonobese patients publication-title: J. Clin. Pharmacol. doi: 10.1002/jcph.505 – volume: 33 start-page: 1256 year: 2013 ident: ref_29 article-title: Adherence to the 2009 consensus guidelines for vancomycin dosing and monitoring practices: A cross-sectional survey of U.S. hospitals publication-title: Pharmacotherapy doi: 10.1002/phar.1327 – volume: 18 start-page: 1450 year: 2008 ident: ref_6 article-title: The eradication of Helicobacter pylori is affected by body mass index (BMI) publication-title: Obes. Surg. doi: 10.1007/s11695-008-9477-z – volume: 37 start-page: 333 year: 2013 ident: ref_3 article-title: Obesity and the risk and outcome of infection publication-title: Int. J. Obes. (Lond.) doi: 10.1038/ijo.2012.62 – volume: 22 start-page: 970 year: 2013 ident: ref_8 article-title: The effect of obesity on antibiotic treatment failure: A historical cohort study publication-title: Pharmacoepidemiol. Drug Saf. doi: 10.1002/pds.3461 – volume: 36 start-page: 585 year: 2017 ident: ref_13 article-title: How obesity impacts outcomes of infectious diseases publication-title: Eur. J. Clin. Microbiol. Infect. Dis. doi: 10.1007/s10096-016-2835-1 – volume: 72 start-page: 933 year: 2017 ident: ref_24 article-title: Sustained impact of a computer-assisted antimicrobial stewardship intervention on antimicrobial use and length of stay publication-title: J. Antimicrob. Chemother. – volume: 31 start-page: 146 year: 2009 ident: ref_17 article-title: Scoring systems for prediction of mortality in patients with intensive care unit-acquired sepsis: A comparison of the Pitt bacteremia score and the Acute Physiology and Chronic Health Evaluation II scoring systems publication-title: Shock doi: 10.1097/SHK.0b013e318182f98f – volume: 37 start-page: 1415 year: 2017 ident: ref_19 article-title: Comprehensive guidance for antibiotic dosing in obese adults publication-title: Pharmacotherapy doi: 10.1002/phar.2023 – volume: 32 start-page: 604 year: 2012 ident: ref_21 article-title: Impact of various body weights and serum creatinine concentrations on the bias and accuracy of the Cockcroft-Gault equation publication-title: Pharmacotherapy doi: 10.1002/j.1875-9114.2012.01098.x – volume: 4 start-page: 277 year: 2010 ident: ref_22 article-title: A modified sequential organ failure assessment score for critical care triage publication-title: Disaster Med. Public Health Prep. doi: 10.1001/dmp.2010.40 – volume: 44 start-page: 979 year: 2013 ident: ref_30 article-title: Prescribing habits of vancomycin in the Emergency Department: Are we dosing appropriately? publication-title: J. Emerg. Med. doi: 10.1016/j.jemermed.2012.11.051 – ident: ref_25 – volume: 2016 start-page: 5941279 year: 2016 ident: ref_26 article-title: The role of obesity in sepsis outcome among critically ill patients: A retrospective cohort analysis publication-title: Biomed. Res. Int. – volume: 59 start-page: e10 year: 2014 ident: ref_34 article-title: Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the Infectious Diseases Society of America publication-title: Clin. Infect. Dis. doi: 10.1093/cid/ciu296 – volume: 19 start-page: 501 year: 2013 ident: ref_11 article-title: Overall burden of bloodstream infection and nosocomial bloodstream infection in North America and Europe publication-title: Clin. Microbiol. Infect. doi: 10.1111/1469-0691.12195 – volume: 140 start-page: 26 year: 2004 ident: ref_18 article-title: International prospective study of Klebsiella pneumoniae bacteremia: Implications of extended-spectrum beta-lactamase production in nosocomial infections publication-title: Ann. Intern. Med. doi: 10.7326/0003-4819-140-1-200401060-00008 – volume: 37 start-page: 1237 year: 2019 ident: ref_23 article-title: Predictive performance of the SOFA and mSOFA scoring systems for predicting in-hospital mortality in the emergency department publication-title: Am. J. Emerg. Med. doi: 10.1016/j.ajem.2018.09.011 – volume: 12 start-page: 4171 year: 2018 ident: ref_10 article-title: Best tigecycline dosing for treatment of infections caused by multidrug-resistant pathogens in critically ill patients with different body weights publication-title: Drug Des. Dev. Ther. doi: 10.2147/DDDT.S181834 – volume: 22 start-page: 671 year: 2016 ident: ref_14 article-title: Impact of body mass index on clinical outcomes in patients with gram-negative bacteria bloodstream infections publication-title: J. Infect. Chemother. doi: 10.1016/j.jiac.2016.07.006 – volume: 27 start-page: 90 year: 2019 ident: ref_16 article-title: Association between body mass index and mortality in patients with gram-negative bloodstream infections publication-title: Infect. Dis. Clin. Pract. doi: 10.1097/IPC.0000000000000711 – volume: 6 start-page: 438 year: 2006 ident: ref_2 article-title: Obesity and infection publication-title: Lancet Infect. Dis. doi: 10.1016/S1473-3099(06)70523-0 – volume: 25 start-page: e224 year: 2018 ident: ref_20 article-title: Influence of morbid obesity on the clinical pharmacokinetics of various anti-infective drugs: Reappraisal using recent case studies-issues, dosing implications, and considerations publication-title: Am. J. Ther. doi: 10.1097/MJT.0000000000000401 – ident: ref_1 doi: 10.1056/NEJMoa1614362 – volume: 30 start-page: 1212 year: 2012 ident: ref_31 article-title: Underdosing of common antibiotics for obese patients in the ED publication-title: Am. J. Emerg. Med. doi: 10.1016/j.ajem.2011.05.027 – volume: 6 start-page: 233 year: 2015 ident: ref_9 article-title: Cellulitis in obesity: Adverse outcomes affected by increases in body mass index publication-title: J. Prim. Care Community Health doi: 10.1177/2150131915583659 – volume: 65 start-page: 128 year: 2012 ident: ref_7 article-title: Risk factors for clinical failure in patients hospitalized with cellulitis and cutaneous abscess publication-title: J. Infect. doi: 10.1016/j.jinf.2012.03.013 |
SSID | ssj0000913808 |
Score | 2.144578 |
Snippet | The impact of adjusted treatment on clinical outcomes in patients with severe obesity is unclear. This study included adults with severe obesity admitted for... |
SourceID | doaj pubmedcentral proquest gale crossref |
SourceType | Open Website Open Access Repository Aggregation Database Enrichment Source Index Database |
StartPage | 707 |
SubjectTerms | Antibiotics Antiinfectives and antibacterials Antimicrobial agents antimicrobials Bacteremia Bacterial infections bloodstream infection Body mass index Care and treatment Clinical outcomes Creatinine Dosage Dosage and administration Drug dosages Drug therapy Gastrointestinal surgery Health services Hemodialysis Hospitalization Hospitals Infections Infectious diseases Mortality Obesity Optimization Overweight persons Patient outcomes Patients prescription Prescriptions Risk analysis Risk factors Sepsis Urea Variables |
SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELZQT1wQT7FQ0CChXmjUOLbj-LgLVC0SsBKt1FvkV0QQzSKye9jfwR9mxslud6kEF25RbCeTzNj-xp75zNjrYLgX3rvMKmMynKFs5lypsqrMhY2N80JRcvLHT-XZpfxwpa52jvqimLCBHnj4cSdcOt4gjtey4tKKxgUXna28jFbGPCRolJt8x5lKY7DhosqrIUtGoF9_gnK2rl0Q97HhieRmbyZKhP23h-U_QyV35p7T--zeCBphOgj7gN2J3UN2NB9Yp9fHcHGTRNUfwxHMb_io14_Yr_MepijXdZtIl_BB7xa0QgDT8G3Vpyhz2GgpBqCVWZilLB_4vFqiRcYe2g7mAwNrP1T4ErEPRBjPFQDbBZhRDDzlnthrOB9jvNBHxnfDEOmXNvSBIhfXj9nl6fuLt2fZeBZD5lXOl5nVwfvcI8AoGiVMqbg1gTvufUSHq9EOr5XkwRfEwGZtqKRAV6xxuS8aK0rxhB10iy4-ZZBrHTTaTrAmyhhK4xGilg4bGCVsFSeMb_RS-5GonM7L-F6jw0K6rG_rcsLebNv8GGg6_lp7Rure1iSK7XQDDa8eDa_-l-FN2CEZS00DAYrnsVv6eoruHG3FconFGyOqx2Ghr9EbVwYhWIHFr7bF1JJC3bq4WGEd2grXiOPVhOk949uTd7-ka78manBdEl4sn_2PD3zO7ha0uJAiFw_ZwfLnKr5ABLZ0L1Nn-w2VgDgD priority: 102 providerName: Directory of Open Access Journals – databaseName: ProQuest Central dbid: BENPR link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9QwELbK9sIF8RQLBRkJ9UKjxrGdxAeEdqFVi8SyglbqLfIrJYgmpdk97O_gDzPjJLsslXqLYju2MuPxzHjmG0LeOsUst9ZEWioVwQmlI2NSGeVpzLUvjeUSk5O_zNKTc_H5Ql7skNmQC4NhlYNMDILaNRZ95IdgyEgFp1ciPlz_jrBqFN6uDiU0dF9awb0PEGP3yC6IZBmPyO70aDb_tva6IApmHudd9gwHe_8Q1l-ZqkFMZMUC-M3WCRWA_G-L6_9DKP85k44fkge9MkknHfUfkR1fPyb78w6NenVAzzbJVe0B3afzDU716gn5c9rSCazrqgpgTPChTw16DujE_Vy2IfqcDtTzjqLHlk5D9g_9ulzAX_MtrWo675BZ267Ddw97w9O-3gDVtaNTjI3HnBR9RU_72C-wnWFu2kUAhot-ihGNq6fk_Pjo7ONJ1NdoiKyM2SLSmbM2tqB4JKXkKpVMK8cMs9aDIVZmBp6lYM4miMymtcsFBxOtNLFNSs1T_oyM6qb2zwmNs8xlwFNOKy-8S5UF1TU1MEBJrnM_JmygS2F7AHOso_GrAEMGaVncpuWYvFuPue7gO-7sPUVyr3si9HZ40dxcFv1OBlvJsBIMy0zkTGheGme80bkVXgsfOz0me8gsBQoIWJ6F7WqLCZh5eEXLBDQPTFT04qItNsw9Jm_WzTgSQ-Bq3yyhD16RZ6DfyzHJtphva73bLXX1I0CGZynqkemLuyd_Se4n6E4IsYp7ZLS4WfpXoHMtzOt-I_0FyHo0qg priority: 102 providerName: ProQuest |
Title | Is Antimicrobial Dosing Adjustment Associated with Better Outcomes in Patients with Severe Obesity and Bloodstream Infections? An Exploratory Study |
URI | https://www.proquest.com/docview/2545919024 https://www.proquest.com/docview/2452978005 https://pubmed.ncbi.nlm.nih.gov/PMC7602836 https://doaj.org/article/14b1f01474814a3fbdbeba8c4ea4e0da |
Volume | 9 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3fb9MwELbG9sILYgNEYVRGQnthgTiOk_gBoXZs2pAYFazS3iL_ygjaEmhaaf07-Ie5c5KOMuCJt6q2Wyd3Z99n331HyAsrmeHG6EAJKQPYoVSgdSKCLAm5coU2XGBy8ofT5Hgavz8X5xukL3fUvcDmj9AO60lNZ5evrr8v34LBv0HECZD9NUyh1GWNtMaSef6aO2TL3xdhKF_n7vuVWTKehVmbO_OXoWv7k6fxv71Y_x5A-cuOdHSf3OtcSTpqZb9NNly1Q_YmLRf1cp-e3aRWNft0j05uWKqXD8iPk4aOYF5Xpadigh96V-O5AR3Zr4vGx57TXnbOUjyvpWOf-0M_Luagp66hZUUnLS9r03b47MAyHO2qDVBVWTrGyHjMSFFX9KSL_ALkDP9N2_g_f81PMZ5x-ZBMjw7PDo6DrkJDYETI5oFKrTGhAbcjKgSXiWBKWqaZMQ5gWJFq-CxiZk2EvGxK2SzmANAKHZqoUDzhj8hmVVfuMaFhmtoUNMoq6WJnE2nAcU00DJCCq8wNCOvlkpuOvhyraFzmAGNQlvltWQ7Iy9WYby15xz97j1Hcq55IvO2_qGcXeWfHgJQ0KwBWpnHGYsULbbXTKjOxU7ELrRqQXVSWHBUWpmfAWE0-ApCHF7QshuZeifJe13PA6EKCYxZB8_NVM47EALjK1QvogxfkKXj3YkDSNeVbm-96S1V-8YThaYJeZPLkfzzgU3I3wiMHH8-4Szbns4V7Bn7ZXA_J1vjwdPJp6M81ht70fgInz0PB |
linkProvider | Scholars Portal |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9NAEF6V9AAXxFMECiwS9EKter1ePw4VSmirhLYhglTqzezLEETtUidC-R38H34bM2s7IVTqrTfL-_DKMzuzMzvzDSGvTco011p5UqSpBxpKekpFwksin0ubK80FJiefjKLBafjhTJxtkD9tLgyGVbYy0QlqU2r0ke-CISNS0F5B-O7ip4dVo_B2tS2hIZvSCmbPQYw1iR1HdvELTLhqb7gP9H4TBIcHk_cDr6ky4Gnhs5knY6O1r0F1BrngaSSYTA1TTGsLpkQeK3gWITM6QGwxKU0ScjAycuXrIJc84jDvLbIZogOlQzb7B6Pxp6WXB1E3Ez-ps3U4T_1d-F9TNS0RgzllDmxnTSO6wgFX1cP_IZv_6MDDe-Ruc3ilvZrb7pMNWzwg2-Ma_XqxQyerZK5qh27T8QoXe_GQ_B5WtAfrOp868CeYaL9ETwXtme_zykW705ZbrKHoIaZ9l21EP85nQCVb0WlBxzUSbFV3-GxhL1ra1DegsjC0j7H4mAMjz-mwiTUDWx2-TeuIQxdYQDGCcvGInN4ItR6TTlEW9gmhfhybGHjYyNSG1kSphqNypGBAKrhMbJewli6ZbgDTsW7HjwwMJ6RldpWWXfJ2Oeaihgu5tncfyb3siVDf7kV5-TVrJAfYZorlYMjGYcJCyXNllFUy0aGVofWN7JItZJYMBRIsT4N40FkPzEq8EmYhNLdMlDXiqcpWm6lLXi2bcSSG3BW2nEMfvJKPwZ4QXRKvMd_aetdbiuk3B1EeR3hujZ5e__GX5PZgcnKcHQ9HR8_InQBdGS5Ocot0Zpdz-xzOezP1otlUlHy56X38F1NacXE |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3db9MwELfGJiFeEJ-iMMBIsBcWNY7z5YcJtXTVyqBUsEl7C_4K68SSsbRC_Tv4r_iruHOSljJpb3urajuxcuc7n_273xHy2gimudbKk5EQHngo6SkVR14a-1zaXGkeYXLyp3F8cBx-OIlONsifNhcGYZWtTXSG2pQaz8i7EMhEArxXEHbzBhYxGQzfXfz0sIIU3rS25TRkU2bB7Dm6sSbJ49AufkE4V-2NBiD7N0Ew3D96f-A1FQc8Hfls5snEaO1rcKNBHnERR0wKwxTT2kJYkScKfkchMzpAnjEpTRpyCDhy5esglzzm8NxbZCsBrw-B4FZ_fzz5sjzxQQbO1E_rzB3Ohd-FbzdV0xL5mAVzxDtr3tEVEbjqKv6Hb_7jD4f3yN1mI0t7tebdJxu2eEB2JjUT9mKXHq0Su6pdukMnK47sxUPye1TRHszrfOqIoOBBgxJPLWjPnM0rh3ynreZYQ_G0mPZd5hH9PJ-BxGxFpwWd1KywVd3hq4V1aWlT64DKwtA-4vIxH0ae01GDO4O4Hd5Na_ShAxlQRFMuHpHjG5HWY7JZlIV9QqifJCYBfTZS2NCaWGjYNscKBoiIy9R2CGvlkumGPB1rePzIIIhCWWZXZdkhb5djLmrqkGt791Hcy55I--3-KC-_Z40VgThNsRyC2iRMWSh5royySqY6tDK0vpEdso3KkqFxgulpMBU660GIidfDLITmVomyxlRV2WphdcirZTOORPhdYcs59MHr-QRii6hDkjXlW5vveksxPXV05UmMe9j46fUvf0luw3rOPo7Gh8_InQBPNRxkcptszi7n9jls_WbqRbOmKPl208v4L13KdbU |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Is+Antimicrobial+Dosing+Adjustment+Associated+with+Better+Outcomes+in+Patients+with+Severe+Obesity+and+Bloodstream+Infections%3F+An+Exploratory+Study&rft.jtitle=Antibiotics+%28Basel%29&rft.au=St%C3%A9phanie+Sirard&rft.au=Claire+Nour+Abou+Chakra&rft.au=Marie-France+Langlois&rft.au=Julie+Perron&rft.date=2020-10-01&rft.pub=MDPI+AG&rft.eissn=2079-6382&rft.volume=9&rft.issue=10&rft.spage=707&rft_id=info:doi/10.3390%2Fantibiotics9100707&rft.externalDBID=DOA&rft.externalDocID=oai_doaj_org_article_14b1f01474814a3fbdbeba8c4ea4e0da |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2079-6382&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2079-6382&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2079-6382&client=summon |